Older adults respond well to immunotherapy despite age-related immune system differences
Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a study by researchers from the Johns Hopkins…
High blood pressure? Eat more bananas
New research from the University of Waterloo suggests increasing the ratio of dietary potassium to sodium intake may be more effective for lowering blood pressure than simply reducing sodium intake.…
New key genes in Parkinson’s disease identified using CRISPR technology
A longstanding mystery in Parkinson’s disease research has been why some individuals carrying pathogenic variants that increase their risk of PD go on to develop the disease, while others who…
For a better cup of coffee, look to physics
The cost of raw arabica beans, the core component of most coffee, has spiked in recent years due to four consecutive seasons of adverse weather. Climate change has added further…
One in 3,000 people at risk of punctured lung from faulty gene
As many as one in 3,000 people could be carrying a faulty gene that significantly increases their risk of a punctured lung, according to new estimates from Cambridge researchers. Previous…
Singapore scientists pioneer non-invasive 3D imaging to transform skin cancer management
Researchers from the Agency for Science, Technology and Research (A*STAR) and the National Healthcare Group (NHG) have jointly pioneered an innovative imaging technique combining Multispectral Optoacoustic Tomography (MSOT) with artificial…
Oral semaglutide vastly reduces heart attacks, strokes in people with type 2 diabetes. New England Journal of Medicine #ACC25
Both the injectable and oral forms of semaglutide, a glucagon-like peptide-1 receptor agonist, have gained recent attention for their effectiveness against weight gain, high blood sugar, and even alcohol cravings.…
A diabetes, heart failure and kidney disease medication (sotagliflozin) is the first of its kind to significantly reduce both heart attacks and strokes
Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart attack and…
Super enzyme breaks down testosterone
We normally associate high testosterone levels with male dominance and aggression. Among ruffs – a shore bird that breeds across Europe and Asia – some males suffer from too much…
Myth busted: Healthy habits take longer than 21 days to set in
We’re nearly one month into 2025, but if you’re struggling to hold onto your New Year’s resolution, stay strong, as University of South Australia research shows that forming a healthy…